1
|
Zhan L, Yin X, Qiu L, Li C, Wang Y. Application of dual chemotherapeutic drug delivery system based on metal-organic framework platform in enhancing tumor regression for breast cancer research. Biochem Biophys Res Commun 2024; 710:149889. [PMID: 38581955 DOI: 10.1016/j.bbrc.2024.149889] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2024] [Revised: 03/26/2024] [Accepted: 04/03/2024] [Indexed: 04/08/2024]
Abstract
The nanomedicine system based on dual drug delivery systems (DDDs) can significantly enhance the efficacy of tumor treatment. Herein, a metal-organic framework, Zeolite imidazole salt frames 8 (ZIF-8), was successfully utilized as a carrier to load the dual chemotherapeutic drugs doxorubicin (DOX) and camptothecin (CPT), named DOX/CPT@ZIF-8 (denoted as DCZ), and their inhibitory effects on 4T1 breast cancer cells were evaluated. The study experimentally demonstrated the synergistic effects of the dual chemotherapeutic drugs within the ZIF-8 carrier and showed that the ZIF-8 nano-carrier loaded with the dual drugs exhibited stronger cytotoxicity and inhibitory effects on 4T1 breast cancer cells compared to single-drug treatment. The use of a ZIF-8-based dual chemotherapeutic drug carrier system highlighted its potential advantages in suppressing 4T1 breast cancer cells.
Collapse
Affiliation(s)
- Lin Zhan
- Institution of Nanochemistry and Nanobiology, School of Environmental and Chemical Engineering & School of Medicine, Shanghai University, Shanghai, 200444, China
| | - Xuelian Yin
- Institution of Nanochemistry and Nanobiology, School of Environmental and Chemical Engineering & School of Medicine, Shanghai University, Shanghai, 200444, China
| | - Li Qiu
- Institution of Nanochemistry and Nanobiology, School of Environmental and Chemical Engineering & School of Medicine, Shanghai University, Shanghai, 200444, China
| | - Chenchen Li
- International Joint Research Center of Human-machine Intelligent Collaborative for Tumor Precision Diagnosis and Treatment of Hainan Province, Engineering Research Center of Tropical Medicine Innovation and Transformation, Ministry of Education, School of Pharmacy & the First Affiliated Hospital, Hainan Medical University, Haikou, 571199, China.
| | - Yanli Wang
- Institution of Nanochemistry and Nanobiology, School of Environmental and Chemical Engineering & School of Medicine, Shanghai University, Shanghai, 200444, China; International Joint Research Center of Human-machine Intelligent Collaborative for Tumor Precision Diagnosis and Treatment of Hainan Province, Engineering Research Center of Tropical Medicine Innovation and Transformation, Ministry of Education, School of Pharmacy & the First Affiliated Hospital, Hainan Medical University, Haikou, 571199, China.
| |
Collapse
|
2
|
Oryani MA, Nosrati S, Javid H, Mehri A, Hashemzadeh A, Karimi-Shahri M. Targeted cancer treatment using folate-conjugated sponge-like ZIF-8 nanoparticles: a review. NAUNYN-SCHMIEDEBERG'S ARCHIVES OF PHARMACOLOGY 2024; 397:1377-1404. [PMID: 37715816 DOI: 10.1007/s00210-023-02707-y] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/13/2023] [Accepted: 09/02/2023] [Indexed: 09/18/2023]
Abstract
ZIF-8 (zeolitic imidazolate framework-8) is a potential drug delivery system because of its unique properties, which include a large surface area, a large pore capacity, a large loading capacity, and outstanding stability under physiological conditions. ZIF-8 nanoparticles may be readily functionalized with targeting ligands for the identification and absorption of particular cancer cells, enhancing the efficacy of chemotherapeutic medicines and reducing adverse effects. ZIF-8 is also pH-responsive, allowing medication release in the acidic milieu of cancer cells. Because of its tunable structure, it can be easily functionalized to design cancer-specific targeted medicines. The delivery of ZIF-8 to cancer cells can be facilitated by folic acid-conjugation. Hence, it can bind to overexpressed folate receptors on the surface of cancer cells, which holds the promise of reducing unwanted deliveries. As a result of its importance in cancer treatment, the folate-conjugated ZIF-8 was the major focus of this review.
Collapse
Affiliation(s)
- Mahsa Akbari Oryani
- Department of Pathology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Shamim Nosrati
- Department of Clinical Biochemistry, Faculty of Medicine, Azad Shahroud University, Shahroud, Iran
| | - Hossein Javid
- Department of Medical Laboratory Sciences, Varastegan Institute for Medical Sciences, Mashhad, Iran.
- Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
- Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
| | - Ali Mehri
- Endoscopic and Minimally Invasive Surgery Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Alireza Hashemzadeh
- Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Mehdi Karimi-Shahri
- Department of Pathology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
- Department of Pathology, School of Medicine, Gonabad University of Medical Sciences, Gonabad, Iran.
| |
Collapse
|
3
|
Myung N, Kang HW. Local dose-dense chemotherapy for triple-negative breast cancer via minimally invasive implantation of 3D printed devices. Asian J Pharm Sci 2024; 19:100884. [PMID: 38357526 PMCID: PMC10861843 DOI: 10.1016/j.ajps.2024.100884] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2023] [Revised: 10/18/2023] [Accepted: 11/18/2023] [Indexed: 02/16/2024] Open
Abstract
Dose-dense chemotherapy is the preferred first-line therapy for triple-negative breast cancer (TNBC), a highly aggressive disease with a poor prognosis. This treatment uses the same drug doses as conventional chemotherapy but with shorter dosing intervals, allowing for promising clinical outcomes with intensive treatment. However, the frequent systemic administration used for this treatment results in systemic toxicity and low patient compliance, limiting therapeutic efficacy and clinical benefit. Here, we report local dose-dense chemotherapy to treat TNBC by implanting 3D printed devices with time-programmed pulsatile release profiles. The implantable device can control the time between drug releases based on its internal microstructure design, which can be used to control dose density. The device is made of biodegradable materials for clinical convenience and designed for minimally invasive implantation via a trocar. Dose density variation of local chemotherapy using programmable release enhances anti-cancer effects in vitro and in vivo. Under the same dose density conditions, device-based chemotherapy shows a higher anti-cancer effect and less toxic response than intratumoral injection. We demonstrate local chemotherapy utilizing the implantable device that simulates the drug dose, number of releases, and treatment duration of the dose-dense AC (doxorubicin and cyclophosphamide) regimen preferred for TNBC treatment. Dose density modulation inhibits tumor growth, metastasis, and the expression of drug resistance-related proteins, including p-glycoprotein and breast cancer resistance protein. To the best of our knowledge, local dose-dense chemotherapy has not been reported, and our strategy can be expected to be utilized as a novel alternative to conventional therapies and improve anti-cancer efficiency.
Collapse
Affiliation(s)
- Noehyun Myung
- Department of Biomedical Engineering, Ulsan National Institute of Science and Technology (UNIST), Ulju-gun 44919, South Korea
| | - Hyun-Wook Kang
- Department of Biomedical Engineering, Ulsan National Institute of Science and Technology (UNIST), Ulju-gun 44919, South Korea
| |
Collapse
|
4
|
He Y, Vasilev K, Zilm P. pH-Responsive Biomaterials for the Treatment of Dental Caries-A Focussed and Critical Review. Pharmaceutics 2023; 15:1837. [PMID: 37514024 PMCID: PMC10385394 DOI: 10.3390/pharmaceutics15071837] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2023] [Revised: 06/20/2023] [Accepted: 06/26/2023] [Indexed: 07/30/2023] Open
Abstract
Dental caries is a common and costly multifactorial biofilm disease caused by cariogenic bacteria that ferment carbohydrates to lactic acid, demineralizing the inorganic component of teeth. Therefore, low pH (pH 4.5) is a characteristic signal of the localised carious environment, compared to a healthy oral pH range (6.8 to 7.4). The development of pH-responsive delivery systems that release antibacterial agents in response to low pH has gained attention as a targeted therapy for dental caries. Release is triggered by high levels of acidogenic species and their reduction may select for the establishment of health-associated biofilm communities. Moreover, drug efficacy can be amplified by the modification of the delivery system to target adhesion to the plaque biofilm to extend the retention time of antimicrobial agents in the oral cavity. In this review, recent developments of different pH-responsive nanocarriers and their biofilm targeting mechanisms are discussed. This review critically discusses the current state of the art and innovations in the development and use of smart delivery materials for dental caries treatment. The authors' views for the future of the field are also presented.
Collapse
Affiliation(s)
- Yanping He
- Adelaide Dental School, University of Adelaide, Adelaide, SA 5000, Australia
| | - Krasimir Vasilev
- College of Medicine and Public Health, Flinders University, Bedford Park, Adelaide, SA 5042, Australia
| | - Peter Zilm
- Adelaide Dental School, University of Adelaide, Adelaide, SA 5000, Australia
| |
Collapse
|
5
|
Chen M, Song F, Wu N, Luo H, Cai X, Li Y. Corn‐like mSiO
2
@ZIF‐8 Composite Load with Curcumin for Target Cancer Drug‐Delivery System. ChemistrySelect 2022. [DOI: 10.1002/slct.202204213] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Affiliation(s)
- Menglan Chen
- School of Pharmacy Guizhou University Guiyang 550025 Guizhou China
- Guizhou Engineering Laboratory for Synthetic Drugs Guizhou University Guiyang 550025 Guizhou
| | - Fangxiang Song
- School of Chemistry and Chemical Engineering Guizhou University Guiyang 550025 Guizhou China
| | - Nian Wu
- School of Pharmacy Guizhou University Guiyang 550025 Guizhou China
- Guizhou Engineering Laboratory for Synthetic Drugs Guizhou University Guiyang 550025 Guizhou
| | - Honghuan Luo
- School of Pharmacy Guizhou University Guiyang 550025 Guizhou China
- Guizhou Engineering Laboratory for Synthetic Drugs Guizhou University Guiyang 550025 Guizhou
| | - Xiaoqin Cai
- School of Pharmacy Guizhou University Guiyang 550025 Guizhou China
- Guizhou Engineering Laboratory for Synthetic Drugs Guizhou University Guiyang 550025 Guizhou
| | - Yan Li
- School of Pharmacy Guizhou University Guiyang 550025 Guizhou China
- Guizhou Engineering Laboratory for Synthetic Drugs Guizhou University Guiyang 550025 Guizhou
| |
Collapse
|
6
|
Chen J, Huang H, Lu R, Wan X, Yao Y, Yang T, Li P, Ning N, Zhang S. Hydrogen-bond super-amphiphile based drug delivery system: design, synthesis, and biological evaluation. RSC Adv 2022; 12:6076-6082. [PMID: 35424584 PMCID: PMC8981983 DOI: 10.1039/d1ra08624c] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2021] [Accepted: 01/25/2022] [Indexed: 02/05/2023] Open
Abstract
Drug delivery systems (DDSs) show great application prospects in tumor therapy. So far, physical encapsulation and covalent grafting were the two most common strategies for the construction of DDSs. However, physical encapsulation-based DDSs usually suffered from low drug loading capacity and poor stability, and covalent grafting-based DDSs might reduce the activity of original drug, which greatly limited their clinical application. Therefore, it is of great research value to design a new DDS with high drug loading capacity, robust stability, and original drug activity. Herein, we report a super-amphiphile based drug delivery system (HBS-DDS) through self-assembly induced by hydrogen bonds between amino-substituted N-heterocycles of the 1,3,5-triazines and hydrophilic carmofur (HCFU). The resulting HBS-DDS had a high drug loading capacity (38.1%) and robust stability. In addition, the drug delivery system exhibited pH-triggered size change and release of drugs because of the pH responsiveness of hydrogen bonds. In particular, the anticancer ability test showed that the HBS-DDS could be efficiently ingested by tumor cells, and its half-maximal inhibitory concentration (IC50 = 3.53 μg mL-1) for HeLa cells was close to that of free HCFU (IC50 = 5.54 μg mL-1). The hydrogen bond-based DDS represents a potential drug delivery system in tumor therapy.
Collapse
Affiliation(s)
- Jiali Chen
- West China School of Nursing/West China Hospital Orthopedics Department, Sichuan University 37 Guo Xue Xiang Chengdu 610041 China
| | - Haolong Huang
- College of Biomedical Engineering and National Engineering Research Center for Biomaterials, Sichuan University 29 Wangjiang Road Chengdu 610064 China +86-28-85411109 +86-28-85411109
| | - Ruilin Lu
- College of Biomedical Engineering and National Engineering Research Center for Biomaterials, Sichuan University 29 Wangjiang Road Chengdu 610064 China +86-28-85411109 +86-28-85411109
| | - Xiaohui Wan
- West China School of Nursing/West China Hospital Orthopedics Department, Sichuan University 37 Guo Xue Xiang Chengdu 610041 China
| | - Yongchao Yao
- College of Biomedical Engineering and National Engineering Research Center for Biomaterials, Sichuan University 29 Wangjiang Road Chengdu 610064 China +86-28-85411109 +86-28-85411109
| | - Tian Yang
- College of Biomedical Engineering and National Engineering Research Center for Biomaterials, Sichuan University 29 Wangjiang Road Chengdu 610064 China +86-28-85411109 +86-28-85411109
| | - Pengfei Li
- College of Biomedical Engineering and National Engineering Research Center for Biomaterials, Sichuan University 29 Wangjiang Road Chengdu 610064 China +86-28-85411109 +86-28-85411109
| | - Ning Ning
- West China School of Nursing/West China Hospital Orthopedics Department, Sichuan University 37 Guo Xue Xiang Chengdu 610041 China
| | - Shiyong Zhang
- College of Biomedical Engineering and National Engineering Research Center for Biomaterials, Sichuan University 29 Wangjiang Road Chengdu 610064 China +86-28-85411109 +86-28-85411109
| |
Collapse
|